Tu1391 PREVALENCE OF ESOPHAGEAL DYSMOTILITY AND GASTROESOPHAGEAL REFLUX IN PATIENTS WITH END STAGE LUNG DISEASE UNDERGOING EVALUATION FOR LUNG TRANSPLANT

2020 ◽  
Vol 158 (6) ◽  
pp. S-1086-S-1087
Author(s):  
Michael Massaro ◽  
Seema Kumar ◽  
James Callaway
Keyword(s):  
Gastroesophageal Reflux ◽  
Lung Disease ◽  
Lung Transplant ◽  
Esophageal Dysmotility ◽  
End Stage

Prevalence of Gastroesophageal Reflux in End-Stage Lung Disease Candidates for Lung Transplant

2005 ◽  
Vol 80 (4) ◽  
pp. 1254-1260 ◽  
Author(s):  
Frank D’Ovidio ◽  
Lianne G. Singer ◽  
Denis Hadjiliadis ◽  
Andrew Pierre ◽  
Thomas K. Waddell ◽  
...  
Keyword(s):  
Gastroesophageal Reflux ◽  
Lung Disease ◽  
Lung Transplant ◽  
End Stage

Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplant

2021 ◽  
Vol 42 (03) ◽  
pp. 380-391
Author(s):  
John W. Stokes ◽  
Whitney D. Gannon ◽  
Matthew Bacchetta
Keyword(s):  
Extracorporeal Membrane Oxygenation ◽  
Lung Disease ◽  
Respiratory Function ◽  
Lung Transplant ◽  
Practice Patterns ◽  
Effective Strategy ◽  
Membrane Oxygenation ◽  
Technological Advances ◽  
Physiologic Condition ◽  
End Stage

AbstractExtracorporeal membrane oxygenation (ECMO) is a cardiopulmonary technology capable of supporting cardiac and respiratory function in the presence of end-stage lung disease. Initial experiences using ECMO as a bridge to lung transplant (ECMO-BTLT) were characterized by high rates of ECMO-associated complications and poor posttransplant outcomes. More recently, ECMO-BTLT has garnered success in preserving patients' physiologic condition and candidacy prior to lung transplant due to technological advances and improved management. Despite recent growth, clinical practice surrounding use of ECMO-BTLT remains variable, with little data to inform optimal patient selection and management. Although many questions remain, the use of ECMO-BTLT has shown promising outcomes suggesting that ECMO-BTLT can be an effective strategy to ensure that complex and rapidly decompensating patients with end-stage lung disease can be safely transplanted with good outcomes. Further studies are needed to refine and inform practice patterns, management, and lung allocation in this high-risk and fragile patient population.

Bilateral lung transplant: the procedure of choice for end-stage septic lung disease

2001 ◽  
Vol 33 (1-2) ◽  
pp. 1622-1623 ◽  
Author(s):  
J.N Rao ◽  
J Forty ◽  
A Hasan ◽  
C.J Hilton ◽  
S Ledingham ◽  
...  
Keyword(s):  
Lung Disease ◽  
Lung Transplant ◽  
Bilateral Lung ◽  
End Stage

Prevalence of Delayed Gastric Emptying and Gastroesophageal Reflux in Patients With End-Stage Lung Disease

2006 ◽  
Vol 82 (4) ◽  
pp. 1570 ◽  
Author(s):  
Matthew P. Sweet ◽  
Charles Hoopes ◽  
Jeffrey Golden ◽  
Steven Hays ◽  
Lorriana Leard ◽  
...  
Keyword(s):  
Gastric Emptying ◽  
Gastroesophageal Reflux ◽  
Lung Disease ◽  
Delayed Gastric Emptying ◽  
End Stage

Lung transplant waiting list: differential outcome of type of end-stage lung disease, one year after registration

1999 ◽  
Vol 18 (6) ◽  
pp. 563-571 ◽  
Author(s):  
Johan De Meester ◽  
Jacqueline M.A Smits ◽  
Guido G Persijn ◽  
Axel Haverich
Keyword(s):  
Lung Disease ◽  
Lung Transplant ◽  
Waiting List ◽  
Differential Outcome ◽  
One Year ◽  
End Stage
Sign in / Sign up

Export Citation Format

Share Document